AstraZeneca’s Imfinzi approved in US as first and only perioperative immunotherapy for patients with early gastric and GEJ cancers: Cambridge, UK Thursday, November 27, 2025, 09 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback